Location: London, UK

Join us as we commemorate 20 years of PTEN-induced kinase 1’s (PINK1) significance in Parkinson’s disease (PD) research. Disruption of mitochondrial quality control pathways has emerged as a central mechanism of PD and is exploited by pharmaceutical companies for novel therapeutics. Discover new insights into PINK1, Parkin, and mitophagy components, as we shed light on neurobiology and immunology. Delve into translational aspects, from cellular models to clinical trials, and connect with experts across academia and industry.

Showcase your research through abstract submissions for oral and poster presentations, with opportunities for flash talks. This conference welcomes early-career researchers, providing networking opportunities and a platform to present your work. This event is ideal for those working in cell biology, biochemistry, neuroscience, pharmaceuticals, biotechnology, and clinical neurology.